ArticleEBioMedicine2015

Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice.

Fatih M Uckun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.